Bank of America’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Sell |
|
|||||
|
2025
Q1 | $307K | Buy |
|
|||||
|
2024
Q4 | $502K | Sell |
|
|||||
|
2024
Q3 | $2.99M | Sell |
|
|||||
|
2024
Q2 | $6.51M | Buy |
|
|||||
|
2024
Q1 | $14.1M | Buy |
|
|||||
|
2023
Q4 | $2.27M | Buy |
|
|||||
|
2023
Q3 | $407K | Sell |
|
|||||
|
2023
Q2 | $5.82M | Sell |
|
|||||
|
2023
Q1 | $12.3M | Buy |
|
|||||
|
2022
Q4 | $4.82M | Buy |
|
|||||
|
2022
Q3 | $7.51M | Buy |
|
|||||
|
2022
Q2 | $7.89M | Sell |
|
|||||
|
2022
Q1 | $12.6M | Sell |
|
|||||
|
2021
Q4 | $22.4M | Buy |
|
|||||
|
2021
Q3 | $14.3M | Sell |
|
|||||
|
2021
Q2 | $23M | Buy |
|
|||||
|
2021
Q1 | $18.2M | Buy |
|
|||||
|
2020
Q4 | $14.1M | Buy |
|
|||||
|
2020
Q3 | $3.85M | Sell |
|
|||||
|
2020
Q2 | $4.21M | Sell |
|
|||||
|
2020
Q1 | $3.15M | Buy |
|
|||||
|
2019
Q4 | $2.33M | Sell |
|
|||||
|
2019
Q3 | $1.95M | Sell |
|
|||||
|
2019
Q2 | $2.81M | Buy |
|
|||||
|
2019
Q1 | $2.13M | Buy |
|
|||||
|
2018
Q4 | $577K | Buy |
|
|||||
|
2018
Q3 | $445K | Sell |
|
|||||
|
2018
Q2 | $407K | Buy |
|
|||||
|
2018
Q1 | $101K | Buy |
|
|||||
|
2017
Q4 | $36K | Buy |
|
|||||
|
2017
Q3 | $9K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $48K | Buy |
|
|||||
|
2016
Q1 | $51K | Buy |
|
|||||
|
2015
Q4 | $43K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $6K | Buy |
|